Centennial Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7K Hold
75
﹤0.01% 269
2025
Q4
$12.7K Hold
75
0.01% 275
2025
Q3
$10.8K Hold
75
﹤0.01% 279
2025
Q2
$9.49K Hold
75
﹤0.01% 286
2025
Q1
$9.59K Hold
75
﹤0.01% 281
2024
Q4
$9.92K Hold
75
﹤0.01% 264
2024
Q3
$10.9K Hold
75
0.01% 267
2024
Q2
$10.3K Sell
75
-2
-3% -$267 0.01% 267
2024
Q1
$10.6K Hold
77
0.01% 269
2023
Q4
$10.5K Hold
77
0.01% 268
2023
Q3
$9.42K Hold
77
0.01% 264
2023
Q2
$9.78K Hold
77
0.01% 267
2023
Q1
$9.95K Hold
77
0.01% 267
2022
Q4
$10.1K Buy
+77
New +$9.95K 0.01% 281

Other funds holding IBB

Centennial Bank's IBB Position: Q1 2026 in Review

Centennial Bank held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 75 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Centennial Bank first reported a position in IBB in Q4 2022 and has held it in 14 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Centennial Bank held 75 shares of iShares Biotechnology ETF worth $12.7K as of Q1 2026.
  • Centennial Bank left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Centennial Bank's portfolio in Q1 2026, its #269 holding.
  • Centennial Bank first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 14 quarters since.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.